Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aculys Pharma, Inc.
Minato-ku, Tokyo, Japanaculys.com ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Other
01
Overview
Completed patient enrollment for Phase 3 clinical trial of pitolisant in patients with narcolepsy in July 2024. Also reported positive Phase 3 clinical study interim analysis results for diazepam nasal spray for epileptic seizures.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Partnerships
Bioprojet SCR (France)Neurelis, Inc. (US)
Beyond the preview
Go deeper on Aculys Pharma, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aculys Pharma, Inc..